14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.27 $7.87 Wednesday, 24th Apr 2024 ARDX stock ended at $6.43. This is 0.626% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.31% from a day low at $6.39 to a day high of $6.66.
90 days $6.27 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Sep 22, 2021 $1.33 $1.33 $1.30 $1.32 1 189 226
Sep 21, 2021 $1.28 $1.32 $1.28 $1.29 1 531 893
Sep 20, 2021 $1.30 $1.34 $1.26 $1.27 2 873 517
Sep 17, 2021 $1.36 $1.36 $1.29 $1.31 7 806 848
Sep 16, 2021 $1.27 $1.35 $1.26 $1.34 3 259 947
Sep 15, 2021 $1.27 $1.30 $1.25 $1.27 2 760 991
Sep 14, 2021 $1.33 $1.35 $1.28 $1.28 3 206 763
Sep 13, 2021 $1.37 $1.37 $1.32 $1.34 2 314 947
Sep 10, 2021 $1.39 $1.44 $1.36 $1.36 2 386 367
Sep 09, 2021 $1.35 $1.39 $1.35 $1.39 1 878 671
Sep 08, 2021 $1.40 $1.42 $1.35 $1.36 3 052 238
Sep 07, 2021 $1.44 $1.46 $1.40 $1.40 3 658 176
Sep 03, 2021 $1.56 $1.58 $1.42 $1.44 14 234 084
Sep 02, 2021 $1.46 $1.47 $1.44 $1.45 1 519 700
Sep 01, 2021 $1.41 $1.47 $1.40 $1.45 2 331 794
Aug 31, 2021 $1.43 $1.46 $1.41 $1.41 2 891 021
Aug 30, 2021 $1.46 $1.47 $1.42 $1.44 2 044 573
Aug 27, 2021 $1.46 $1.49 $1.40 $1.45 3 344 906
Aug 26, 2021 $1.41 $1.46 $1.40 $1.45 2 927 650
Aug 25, 2021 $1.49 $1.49 $1.39 $1.40 4 623 182
Aug 24, 2021 $1.45 $1.48 $1.41 $1.47 2 749 947
Aug 23, 2021 $1.37 $1.45 $1.37 $1.44 3 382 749
Aug 20, 2021 $1.32 $1.40 $1.28 $1.34 3 621 879
Aug 19, 2021 $1.34 $1.39 $1.32 $1.32 3 587 145
Aug 18, 2021 $1.45 $1.46 $1.36 $1.37 4 752 053
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT